• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

12 Drugs Approved for Primary Care in 2021

News
Slideshow

With 2021 nearing an end, Patient Care Online has compiled a list of key drugs approved this year by the US Food and Drug Administration for conditions that are often seen in primary care. Scroll through the slides below to find details on the novel COVID-19 vaccine, a novel agent for the treatment of heart failure, the first and only antihistamine nasal spray for allergies available over-the-counter, and 9 more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

Grace Halsey
September 10th 2025
Article

Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
August 28th 2025
Podcast

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

Pharmacy-Based FIT Distribution May Expand CRC Screening: Daily Dose / image credit: ©New Africa/AdobeStock

First Generic GLP-1 RA Approved for Weight Management in the US: Daily Dose

Sydney Jennings
September 10th 2025
Article

Your daily dose of the clinical news you may have missed.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 7th 2025
Podcast

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension / image credit ©Sundry Photos

Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension

Grace Halsey
September 9th 2025
Article

Zilebesiran’s twice-yearly dosing and sustained BP reductions could offer a new therapeutic approach for adults with resistant hypertension and high CV risk who are uncontrolled on current SOC regimens.

Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds

Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds

Sydney Jennings
September 8th 2025
Article

Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.

© 2025 MJH Life Sciences

All rights reserved.